Zanubritnib and Anti-MAG Neuropathy

NCT07392229 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Anti-MAG IgM-associated Demyelinating Polyneuropathy

Interventions

DRUG: Zanubrutinib Oral Capsule

Sponsor

Azienda Ospedaliera di Padova

Collaborators

[object Object]